the Effect of Ginkgo Biloba on Rheumatoid Arthritis Patients
Starting soon · Phase 2/Phase 3
Conditions studied: Rheumatoid Arthritis (RA), Manegmentof Rheumatoid Arthritis
In brief
this study aims to measure The Effect of Gingko Biloba on the Clinical Outcome of Rheumatoid Arthritis Patients ,the outcomes are hsCRp,calprotectin,DAS-28,HAQ-DI
Key facts
- Study ID
- NCT07709312
- Run by
- Ain Shams University
- People needed
- 50
- Starts
- 2026-07-15
- Expected to finish
- 2026-10-15
- Last updated by the study team
- 2026-07-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- 1. Patients with known hypersensitivity to Ginkgo biloba 2. Patients receiving Ginkgo biloba for any other indications 3. Patients on biologic DMARDs 4. Patients with impaired liver functions (liver transaminases level ≥ three times upper normal limits), impaired kidney functions (estimated glomerular filtration rate (eGFR) < 30 ml/min), 5. Patients with any of the following comorbidities: congestive heart failure, history of myocardial infarction, severe anemia, active infections, other inflammatory diseases, and malignancies.
- Patients with other autoimmune diseases
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.